Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer.

AUTOR(ES)

Sehgal, I

RESUMO

After therapeutic hormone deprivation, prostate cancer cells often develop androgen-insensitive growth through mechanisms thus far undefined. Neuropeptides have been previously implicated as growth factors in some prostate cancers. Here, we demonstrate that androgen-sensitive LNCaP human prostate cancer cells produce and secrete neurotensin following androgen withdrawal. We show that while LNCaP cells express the neurotensin receptor, only androgen-deprived cells exhibit a growth response to exogenous neurotensin. We further demonstrate that androgen-stimulated cells may be refractory to exogenous neurotensin due to androgen induction of a metalloprotease active toward neurotensin. Thus, prostate cancer cells deprived of androgen develop an alternative autocrine growth mechanism involving neurotensin.

Documentos Relacionados

• Androgen receptor gene mutations in human prostate cancer.
• T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer
• Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.
• Complete androgen blockade for metastatic prostate cancer.
• Neurotensin regulates growth of human pancreatic cancer.